On February 9, VIVEbiotech obtained the authorization from the Spanish Agency of Medicines and Medical Devices (AEMPS) to manufacture investigational medicinal products.

The new document reflects the following scope and dosage forms:

  • Manufacturer of sterile or biological active substances
  • Manufacturer of investigational medicinal products

The new authorization of “Manufacturer of investigational medicinal products” authorizes VIVEbiotech to manufacture drugs that will be administered in vivo in clinical trials.

You can check the new authorization issued by the AEMPS here.